2025 Annual Report & Financial Statements

Summary by AI BETAClose X

Asiamet Resources Limited has released its audited 2025 annual report, highlighting significant progress on its BKM Copper Project with updated ore reserves of 28.3 million tonnes at 0.7% Cu, totaling 207,000 tonnes of contained copper. The Optimised Feasibility Study projects approximately 10,000 tonnes of copper cathode production annually over a 13-year mine life, with life-of-mine revenues of $1.192 billion and EBITDA of $612.2 million. The company also raised $5.6 million through share placements and is progressing the proposed sale of its KSK Project for $105 million. Financially, Asiamet reported cash of $3.4 million at year-end 2025, an increase from $2.3 million in 2024, while the net loss for the year was $4.87 million, an improvement from $5.46 million in the prior year.

Disclaimer*

Asiamet Resources Limited
26 May 2026
 

26 May 2026

 

2025 Annual Report & Financial Statements

 

Asiamet Resources Limited ("Asiamet" or the "Company") is pleased to present its audited financial statements for the 12 months ended 31 December 2025 ("Financial Statements") as extracted from the Company's 2025 Annual Report which is now available on the Company website at www.asiametresources.com and will be provided to shareholders who have requested a printed or electronic copy. 

The Financial Statements are set out below and should be read in conjunction with the 2025 Annual Report which contains the notes to the Financial Statements. 

All dollars in the report are US$ unless otherwise stated. 

Key 2025 Financial and Operational Highlights Include: 

BKM Copper Project (Asiamet 100%)

Updated Ore Reserve for BKM Stage 1 (see announcement dated 2 May 2025)

Key Highlights

·    BKM Stage 1 Ore Reserves now comprise:

Proved Reserve Category: 15.0Mt @ 0.8% Cu for 117kt of contained copper

Probable Reserve Category: 13.3Mt @ 0.7% Cu for 90kt of contained copper

Total Ore Reserves: 28.3Mt @ 0.7% Cu for 207kt of contained copper

·    Strip ratio 0.8:1

·    Mining/Processing Method: Ore Reserves reported based on extraction by open-pit mining with heap-leach and solvent extraction / electro-winning ("SX-EW") processing

·    Reserve Basis: Ore Reserves are constrained by BKM Stage 1 Optimised Feasibility Study 2025 heap leach facility design

Completion of BKM Stage 1 Copper Project Optimised Feasibility Study ("OFS") (see announcement dated 7 May 2025)

Key Highlights:

·    Annual copper cathode production of approximately 10k tonnes with a ~13 year mine life

·    Life-of-mine revenues of US$1.192 billion and EBITDA of US$612.2 million[1]

·    Initial capital cost of US$178.4 million, including US$11.1 million (7.6%) growth allowance and US$21.8 million (~13.9%) contingency

·    Post-tax NPV81 of US$122.4 million, post-tax IRR1 of 17.7%, and payback period of 4.5 years

·    Life-of-mine production of 124,022 tonnes of LME Grade A copper cathode

·    Low strip ratio of 0.77:1, Life-of-Mine C1 costs of US$1.79/lb and AISC of US$2.37/lb

Corporate:

·    The Company successfully raised US$2.5 million via direct share placement to PT BUMA International Tbk ("BUMA") (see announcement dated 29 May 2025) and successfully raised another US$3.1 million through a direct share placement to existing shareholders and several new investors (see announcement dated 17 December 2025).

·    Appointment of Shore Capital as Corporate Broker and Grant Samuel as Financial Adviser to lead the Strategic Investor Engagement Process for the BKM Copper Project.

·    Proposed Sale of Asiamet's Interest in the KSK Project to Norin Mining for gross consideration of US$105 million on a cash-free, debt-free basis (see announcement dated 6 November 2025).

·    The Company successfully completed a resource definition drilling programme targeting limestone at the Rinjen prospect on the KSK CoW (see announcement dated 15 September 2025).

 

The 2025 Annual Report can be viewed at: http://www.rns-pdf.londonstockexchange.com/rns/7702F_1-2026-5-26.pdf

 

Update on Proposed Sale of Indokal Limited

As previously announced, shareholder approval from Asiamet shareholders and the relevant Chinese regulatory approvals have both been obtained.

The remaining Indonesian regulatory processes and associated completion workstreams continue to progress. The Company continues to work closely with relevant stakeholders in relation to these matters and progress is being made.

The Company and the purchaser remain actively engaged through the completion process, and the Board will continue to update shareholders as appropriate.

 

ON BEHALF OF THE BOARD OF DIRECTORS

Antony (Tony) Manini, Chairman

 

For further information, please contact:

Tony Manini
Chairman, Asiamet Resources Limited
Email:
tony.manini@asiametresources.com

 

Investor Enquiries

Sasha Sethi

Telephone: +44 (0) 7891 677 441

Email: Sasha@flowcomms.com
Email: info@asiametresources.com

Nominated & Financial Adviser
Strand Hanson Limited

James Spinney / James Dance / Rob Patrick

Telephone: +44 20 7409 3494

Email: asiamet@strandhanson.co.uk

 

Broker

Shore Capital

Toby Gibbs / George Payne

Telephone: +44 20 7408 4050

 

Follow us on X @AsiametTweets

 

FORWARD-LOOKING STATEMENT

This news release contains forward-looking statements that are based on the Company's current expectations and estimates. Forward-looking statements are frequently characterised by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "suggest", "indicate" and other similar words or statements that certain events or conditions "may" or "will" occur. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual events or results to differ materially from estimated or anticipated events or results implied or expressed in such forward-looking statements.   Such factors include, among others: the actual results of current exploration activities; conclusions of economic evaluations; changes in project parameters as plans continue to be refined; possible variations in ore grade or recovery rates; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing; and fluctuations in metal prices.  There may be other factors that cause actions, events or results not to be as anticipated, estimated or intended.  Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to the inherent uncertainty therein.

 

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

 



 

Consolidated Statement of Financial Position

As at 31 December 2025



2025

2024

 

 

 $'000

 $'000

 




Assets

 


Current assets

 



Cash

 3,405

 2,279


Receivables and other assets

 9

 275



 3,414

 2,554


Assets classified as held for sale

 373

 -



 3,787

 2,554

Non-current assets

 



Plant and equipment

 -

 137


Right-of-use asset

 -

 42


Receivables and other assets

 3

 116



 3

 295

Total assets

 3,790

 2,849





Liabilities and Equity

 


Current liabilities

 



Trade and other payables

 192

 405


Provisions

 -

 24


Lease liabilities

 -

 36



 192

 465


Liabilities directly associated with the assets classified as held for sale

 710

 -



 902

 465

Non-current liabilities

 



Provisions

                56

 640



 958

 1,105

Equity

 



Share capital

 33,899

 29,725


Equity reserves

 69,251

 67,506


Other comprehensive Income

 242

 202


Accumulated Deficit

 (97,307)

 (92,436)


Other reserves

 (3,246)

 (3,246)


Parent entity interest

 2,839

 1,751


Non-controlling interest

 (7)

 (7)



 2,832

 1,744

Total liabilities and equity

 3,790

 2,849

 

 

 

 

 

 

 

 

Consolidated Statement of Comprehensive Loss

For the year ended 31 December 2025



2025

2024

 

 

 $'000

 $'000

 








Continuing Operations

 


Expenses

 



Exploration and evaluation

 (149)

 (118)


Employee benefits

 (145)

 (667)


Consultants

 (520)

 (133)


Legal and Company Secretarial

 (124)

 (105)


Accounting and audit

 (44)

 (38)


General and administrative

 (211)

 (188)


Depreciation

 -

 (2)


Share-based compensation

 (379)

 (405)



 (1,572)

 (1,656)

Other Items

 



Foreign exchange losses

       (10)

 (25)


Finance costs

           -

 -


Impairment expense

         (66)

 (136)


Other income

              32

 77



 (44)

 (84)

Net loss before tax from continuing operations

 (1,616)

 (1,740)


Income tax expense

   -

          -

Net loss for the year from continuing operations

     (1,616)

(1,740)

Discontinued operations

 



Loss after tax for the year from discontinued operations

(3,255)

(3,724)

Net loss for the year

                  (4,871)

                (5,464)

Item that may not be reclassified subsequently

 


to profit or loss:

 



Actuarial gain on employee service entitlements

              40

76

Total comprehensive loss for the year

(4,831)

(5,388)

Net loss attributable to:

 



Equity holders of the parent

 (4,820)

 (5,418)


Non-controlling interests

 (51)

 (46)





Total comprehensive loss attributable to:

 



Equity holders of the parent

 (4,780)

 (5,342)


Non-controlling interests

 (51)

 (46)





Basic and diluted loss per common share (cents per share)

 (0.16)

 (0.20)

Consolidated Statement of Cash Flows          

For the year ended 31 December 2025



2025

2024

 

 

 $'000

 $'000

 












Operating activities

 


Loss before tax from continuing operations

          (1,616)

          (1,740)

Loss before tax from discontinued operations

          (3,255)

          (3,724)

Loss before tax

 (4,871)

 (5,464)

Adjustment for:

 



Depreciation

 (5)

 27


Share-based compensation

 379

 405


Net foreign exchange loss/(gain)

 (24)

 (19)


Impairment expense

 114

 136


Finance cost

 2

 2


Adjustment to provisions

 81

 (144)

Changes in working capital:

 



Receivables and other assets

 161

 (331)


Trade and other payables

 (131)

 135



 (4,294)

 (5,253)

Other adjustments:

 


Payment of employee entitlement

 (4)

 -

 Interest payments

 (2)

 (2)

Net cash flows used in operating activities

 (4,300)

 (5,255)





Investing activities

 


Purchase of property, plant and equipment

 (16)

 (120)

Net cash flows used in investing activities

 (16)

 (120)





Financing activities

 


Payment of principal portion of lease liabilities

 (28)

 (20)

Proceeds from equity raising

 5,601

 3,594

Equity raising costs

 (61)

 (47)

Net cash flows from financing activities

 5,512

 3,527

Net Increase in cash

 1,196

 (1,848)

Net foreign exchange differences

 -

 (9)

Cash at beginning of the year

 2,279

 4,136

Cash at end of the year

 3,475

 2,279

 

 


Consolidated Statement of Changes in Equity

For the year ended 31 December 2024








Total equity

 






Other

 


attributable

Non-

 



 Share

Equity

comprehensive

Accumulated

Other

to the

controlling

 



capital

reserves

(income)/loss

deficit

reserves

parent

interests

Total

 

 

 $'000

$'000

$'000

$'000

$'000

$'000

$'000

$'000

 










Balance at 1 January 2024

 25,902

 67,378

 126

 (86,972)

 (3,246)

 3,188

 (7)

 3,181












Loss for the year

 -

 -

 -

 (5,418)

 -

 (5,418)

 (46)

 (5,464)


Other comprehensive income

 -

 -

 76

 -

 -

 76

 -

 76

Total comprehensive loss

 -

 -

 76

 (5,418)

 -

 (5,342)

 (46)

 (5,388)











Transactions with owners in their capacity as owners

 









Equity raising

3593

1

 -

 -

 -

 3,594

 -

 3,594


Equity raising costs

 -

 (47)

 -

 -

 -

 (47)

 -

 (47)


Reclassify shares issued to directors

 99

 (99)

 -

 -

 -

 -

 -

 -


Share based compensation

 131

 274

 -

 -

 -

 405

 -

 405


Contribution by parent in NCI

 -

 -

 -

 (46)

 -

 (46)

 46

 -


(see note 17b)









Balance at 31 December 2024

 29,725

 67,506

 202

 (92,436)

 (3,246)

 1,751

 (7)

 1,744

 

 

Consolidated Statement of Changes in Equity

For the year ended 31 December 2025








Total equity

 






Other

 


attributable

Non-

 



 Share

Equity

comprehensive

Accumulated

Other

to the

controlling

 



capital

reserves

loss

deficit

reserves

parent

interests

Total

 

 

 $'000

$'000

$'000

$'000

$'000

$'000

$'000

$'000

 










Balance at 1 January 2025

 29,725

 67,506

 202

 (92,436)

 (3,246)

 1,751

 (7)

 1,744

 











Loss for the year

 -

 -

 -

 (4,820)

 -

 (4,820)

 (51)

 (4,871)

 

Other comprehensive loss



 40

 


 40

 

 40

Total comprehensive income

 -

 -

 40

 (4,820)

 -

 (4,780)

 (51)

 (4,831)

 










Transactions with owners in their capacity as owners

 









Equity raising

 3,860

 1,741

 -

 -

 -

 5,601

 -

 5,601

 

Equity raising costs

 -

 (61)

 -

 -

 -

 (61)

 -

 (61)

 

Reclassify shares issued to directors

 152

 (152)

 -

 -

 -

 -

 -

 -

 

Share based compensation

 162

 217

 -

 -

 -

 379

 -

 379

 

Contribution by parent in NCI

 -

 -

 -

 (51)

 -

 (51)

 51

 -

 

(see note 17b)









Balance at 31 December 2025

 33,899

 69,251

 242

 (97,307)

 (3,246)

 2,839

 (7)

 2,832

 

 

 



[1]Excluding closure and rehabilitation costs

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings